https://www.business-standard.com/article/news-cm/strides-pharma-science-suspends-sale-of-ranitidine-tablets-in-the-us-market-119092700221_1.html
Strides Pharma Science suspends sale of Ranitidine tablets in the US market
The Company predominantly sells Ranitidine tablets in the US markets, and its front end sales globally for the product were ~US$ 9 million in H1FY20.
strides pharma sciencein the ussale of